Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Oropharyngeal Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
14 drugs · 85 active trials
1 drug · 0 active trials
0 drugs · 0 active trials
no drug at this stage
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 19 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Cisplatin | Phase 3 | Phase 3 | 32 | 15 | 13 | 69 | 0 | — | — | 1999-07 |
| Pembrolizumab | Phase 3 | Phase 3 | 14 | 7 | 2 | 19 | 0 | — | — | 2015-11 |
| Carboplatin | Phase 3 | Phase 3 | 13 | 5 | 2 | 25 | 0 | — | — | Apr 25, 2007 |
| Paclitaxel | Phase 3 | Phase 3 | 6 | 2 | 1 | 14 | 0 | — | — | Apr 25, 2007 |
| Cetuximab | Phase 3 | Phase 3 | 4 | 3 | 8 | 26 | 0 | — | — | 2005-01 |
| Docetaxel | Phase 3 | Phase 3 | 3 | 1 | 4 | 12 | 0 | — | — | 2002-09 |
| Durvalumab | Phase 3 | Phase 3 | 3 | 0 | 2 | 9 | 0 | — | — | 2015-07 |
| Fluorouracil | Phase 3 | Phase 3 | 3 | 1 | 2 | 9 | 0 | — | — | 1999-07 |
| Nivolumab | Phase 3 | Phase 3 | 3 | 1 | 1 | 8 | 0 | — | — | Jan 30, 2017 |
| Bevacizumab | Phase 3 | Phase 3 | 1 | 0 | 1 | 5 | 0 | — | — | 2001-07 |
| Cyclophosphamide | Phase 3 | Phase 3 | 1 | 0 | 1 | 5 | 0 | — | — | 2010-12 |
| Atezolizumab | Phase 3 | Phase 3 | 1 | 1 | 1 | 2 | 0 | — | — | Mar 22, 2013 |
| Tretinoin | Phase 3 | Phase 3 | 1 | 1 | 1 | 1 | 0 | — | — | Feb 20, 2025 |
| Dexamethasone | Phase 3 | Phase 3 | 0 | 0 | 1 | 3 | 0 | — | — | 2009-02 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.